Key takeaways
- Telehealth changes the delivery of care, not the standard, so judge a clinic on what happens before a prescription is written and what is scheduled after it.
- Comprehensive bloodwork exists because the symptoms of low testosterone are non-specific and overlap with thyroid disease, iron deficiency, sleep apnoea and depression.
- LH and FSH separate primary from secondary hypogonadism, which decides whether replacement is the right treatment at all.
- Scheduled hematocrit monitoring exists because testosterone reliably raises red cell production, and the rise is silent until it is not.
- A bundled aromatase inhibitor on day one, an unnamed pharmacy, or no named prescriber are the red flags that matter most.
The question is usually asked in a defensive way — is this real medicine, or is it a website that sells hormones. Both exist, they look similar from the outside, and the marketing does not distinguish them. What distinguishes them is a short list of things that either happen before a prescription is written or do not. Once you know what that list is, telling the two apart takes about ten minutes on a clinic's own website.
What legitimate telehealth actually does
Testosterone therapy is not a complicated medicine to prescribe. It is a demanding one to manage, because it suppresses the axis it supplements, it changes red blood cell production, and it converts into estradiol at a rate that varies enormously between individuals. Everything on the list below exists because one of those three facts can hurt someone.
- Require comprehensive bloodwork before prescribing — total and free testosterone, SHBG, sensitive estradiol, full thyroid, lipids, a metabolic panel and CBC at minimum (Rosner et al., J Clin Endocrinol Metab 2007)
- Have you consult with a U.S.-licensed physician licensed in your state
- Prescribe through a U.S. FDA-registered pharmacy, 503A compounding or commercial
- Provide scheduled lab follow-up — at minimum around month three, month six, and annually thereafter (Bhasin et al., J Clin Endocrinol Metab 2018)
- Give you physician access for ongoing questions and dose adjustment
- Use a sensitive (LC-MS/MS) estradiol assay for men, because the standard immunoassay is unreliable at male concentrations
- Have written protocols for complications, particularly rising hematocrit (Ohlander et al., Sex Med Rev 2018)
Professional guidance for testosterone deficiency has converged on the same structure — confirm the diagnosis on more than one measurement, evaluate the cause, then monitor deliberately rather than reactively (Mulhall et al., AUA guideline, J Urol 2018).
Why each safeguard exists
A checklist is easy to ignore when you do not know what it is protecting you from. Each item maps to a specific failure.
Bloodwork before prescribing exists because the symptoms of low testosterone are almost perfectly non-specific. Fatigue, low drive, poor sleep, weight gain and low mood are equally the presentation of hypothyroidism, iron deficiency, sleep apnoea, depression and chronic under-eating. Treating all of those with testosterone means treating some wrongly and leaving the real problem in place. Confirmation on more than one morning draw matters too, because a single low value is often just a bad night's sleep.
LH and FSH separate primary from secondary hypogonadism — a testicular problem versus a signalling problem — and secondary hypogonadism sometimes has a treatable upstream cause that makes lifelong replacement unnecessary.
Sensitive estradiol matters because estradiol in men is not a side effect to be minimised; it is a required hormone that happens to be made from testosterone, and it is measured at concentrations where the ordinary assay is not accurate. Estradiol's role in men covers why crushing it is the more common error.
Hematocrit monitoring exists because testosterone reliably stimulates red blood cell production, and in a subset of men it climbs high enough to need a dose change. That is silent until it is not, which is exactly why it is scheduled rather than symptom-triggered. Managing hematocrit on TRT goes through the response.
Physician access after starting exists because the first three months are when dose, injection frequency and side effects get sorted out. A clinic that will sell you a vial but not answer a question in week six has sold you a product, not care.
Red flags
- Prescribing without bloodwork, or on a questionnaire alone
- Only a total testosterone, with no SHBG, LH, FSH or estradiol
- Standard rather than sensitive estradiol assay for men
- No stated monitoring schedule anywhere on the site
- No way to reach a physician after the first consultation
- The same protocol for everyone regardless of labs
- Source pharmacy unnamed or unverifiable
- Anastrozole or HCG bundled in on day one with no indication
- "Research" peptides, unbranded vials, or overseas pharmacies
- No named prescribing physician anywhere
The bundled aromatase inhibitor deserves particular attention, because it is the most common way a legitimate-looking service does harm. Prescribing something to suppress estradiol before you know what a man's estradiol is doing is not personalisation; it is a default, and the default is wrong often enough to matter.
Green flags
- Comprehensive bloodwork required up front, not just total testosterone
- Named, U.S.-licensed prescribing physicians
- Clearly identified U.S., FDA-registered pharmacy partners
- Real clinical content, not only marketing pages
- A published, transparent monitoring schedule
- More than one treatment path offered — enclomiphene and HCG among them — chosen from labs rather than from inventory
- Physician-reviewed lab interpretation, explained to you
- An obvious channel for questions between visits
The tell that carries the most weight is the last one on the red-flag list combined with the second on this one. Legitimate prescribers are willing to be named. If nobody's licence is attached to your prescription in a way you can check, that is not an oversight.
The regulatory framework, briefly
Legitimate telehealth operates inside structures that already existed: state medical licensing for the prescriber, FDA registration for the pharmacy (503A compounding or 503B outsourcing), and DEA registration because testosterone is a Schedule III controlled substance in the United States. None of that is telehealth-specific. The framework is the same as in-person care; the delivery method is what differs, and the delivery method is not the part that determines quality.
Evaluations of direct-to-consumer platforms have found real variation in how closely they follow guideline practice, which is the honest reason this article exists rather than a reassurance that everything online is fine (direct-to-consumer testosterone platform evaluations).
Telehealth versus in-person
| Factor | Telehealth (legitimate) | In-person |
|---|---|---|
| Lab work | Local Quest or LabCorp draw | In-clinic or local lab |
| Physician evaluation | Video consultation | Office visit |
| Prescription | FDA-registered pharmacy | FDA-registered pharmacy |
| Ongoing access | Messaging plus scheduled review | Phone calls, periodic visits |
| Lab monitoring | Same standard | Same standard |
| Physical examination | Not performed remotely | Available |
| Quality of care | Equivalent when reputable | Variable |
The one genuine asymmetry is the physical examination. For most men evaluated for hypogonadism it changes little, because the diagnosis is made from history and blood. Where it matters — a testicular abnormality, suspected pituitary disease, a prostate concern — a good remote service refers rather than works around it. A service that never refers anyone in person is telling you something.
The clinical pearl: telehealth does not change the standard of care; it changes the delivery. Judge a clinic on what has to happen before a prescription is written and what is scheduled after it — comprehensive labs, a named physician, a real monitoring calendar. Everything else on the website is decoration.
How to check a clinic in ten minutes
- Find the panel they require before prescribing. If it is not published, ask. If it is total testosterone only, stop.
- Find the name of a prescribing physician and confirm the licence in your state's medical board lookup.
- Find the pharmacy. It should be named, U.S.-based and verifiable.
- Find the monitoring schedule. A specific calendar, not "we monitor closely".
- Ask what happens if hematocrit rises. A clinic with an answer has thought about it.
- Ask what alternatives they offer if labs point to secondary hypogonadism with a reversible cause.
A related piece, how to choose a telehealth provider, applies the same tests across treatment categories, and why bloodwork comes before treatment explains the first item at length.
Bottom line
Telehealth TRT is fully legitimate when the clinic works to professional standards: comprehensive labs before prescribing, confirmation on more than one draw, a named U.S.-licensed physician, a U.S. FDA-registered pharmacy, a written monitoring schedule, and someone to answer questions in month two. The convenience is real, and none of it requires giving up the safeguards. The work is on you only once: recognising, before you hand over a card, whether a service is practising medicine or processing orders. The 60-second assessment shows what a structured intake looks like.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
